Risperidone versus typical antipsychotic medication for schizophrenia
β Scribed by William T. Carpenter
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 64 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1523-3812
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective An international, nonβrandomised study evaluated efficacy and safety of risperidone longβacting injectable (RLAI) compared to previous treatment. To investigate generisability of the European data set to the UK subset safety and switching data are reported here. ## Method
## Abstract ## Objective To evaluate the effectiveness of antipsychotic polypharmacy in a methodologically sound manner. ## Methods In this openβlabel study, 17 patients with treatmentβrefractory schizophrenia, who failed to respond to a sequential monotherapy with olanzapine, quetiapine and ris